Home › NDC Lookup › RxCUI directory › RxCUI 208397

Dinoprostone 0.000167 MG/MG Vaginal Gel [Prepidil] — RxCUI 208397

RxNorm drug concept · Semantic branded drug
RxCUI 208397 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI208397
Official nameDinoprostone 0.000167 MG/MG Vaginal Gel [Prepidil]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPrepidil 0.000167 MG/MG Vaginal Gel; Prepidil 0.5 MG per 3 GM Vaginal Gel; PGE2 0.000167 MG/MG Vaginal Gel [Prepidil]
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dinoprostone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dinoprostone is a medication that mimics a natural hormone your body makes during late pregnancy to help prepare your cervix for labor. Your cervix needs to soften, thin out, and b...
  • What exactly is dinoprostone, and why do I need it?
  • Yes, you'll be awake throughout. Dinoprostone is placed in your vagina or cervix by your care team, and you'll be monitored closely the whole time. Some women feel mild cramping or...
  • Will I be awake and aware during the process? What will it feel like?
📖 Read our full Dinoprostone guide →

🕸️ Concept Web — How Dinoprostone 0.000167 MG/MG Vaginal Gel [Prepidi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dinoprostone 0.000167 MG/MG Vaginal Gel [Prepidil] RxCUI 208397

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dinoprostone 3478
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prepidil 152247
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dinoprostone Vaginal Gel 377266
    • Dinoprostone Vaginal Product 1152203
    • Dinoprostone Vaginal Gel [Prepidil] 367177
    • Prepidil Vaginal Product 1185865
    • Vaginal Gel 11108
    • Vaginal Product 1151125
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Dinoprostone 0.000167 MG/MG [Prepidil] SBDC · 569096
  • Dinoprostone Vaginal Gel [Prepidil] SBDF · 367177
  • Prepidil Vaginal Product SBDG · 1185865
  • Prepidil BN · 152247

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 208397 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-3359-01 1 SYRINGE in 1 CARTON (0009-3359-01) / 3 g in 1 SYRINGE Prepidil Pharmacia & Upjohn Company LLC 2019-12-11
Observed labelers: Pharmacia & Upjohn Company LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.